Biological Therapies in Immune-Mediated Inflammatory Diseases: Can Biosimilars Reduce Access Inequities?

Biological therapies are an effective treatment for a range of immune-mediated inflammatory diseases (IMIDs), including rheumatoid arthritis, psoriasis, and inflammatory bowel diseases. However, due to their high costs, considerable differences in their utilization exist across the world, even among...

Descripción completa

Detalles Bibliográficos
Autores principales: Baumgart, Daniel C., Misery, Laurent, Naeyaert, Sue, Taylor, Peter C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6447826/
https://www.ncbi.nlm.nih.gov/pubmed/30983996
http://dx.doi.org/10.3389/fphar.2019.00279

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6447826/
https://www.ncbi.nlm.nih.gov/pubmed/30983996
http://dx.doi.org/10.3389/fphar.2019.00279

Ejemplares similares